101 related articles for article (PubMed ID: 22217151)
1. Relevance of the POS-1 orthotopic model as an "imaging model" for in vivo and simultaneous monitoring of tumor proliferation and bone remodeling in osteosarcoma.
Miot-Noirault E; Gouin F; Dauplat MM; Heymann D; Chezal JM; Redini F
Cancer Biother Radiopharm; 2012 Feb; 27(1):96-103. PubMed ID: 22217151
[TBL] [Abstract][Full Text] [Related]
2. Intense uptake of Tc-99m HMDP in pleural metastasis from osteosarcoma.
Biyi A; Doudouh A; Albouzidi A; Zekri A
Clin Nucl Med; 2006 Jul; 31(7):423-4. PubMed ID: 16785816
[No Abstract] [Full Text] [Related]
3. Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma.
Franzius C; Bielack S; Flege S; Sciuk J; Jürgens H; Schober O
J Nucl Med; 2002 Aug; 43(8):1012-7. PubMed ID: 12163625
[TBL] [Abstract][Full Text] [Related]
4. Tl-201 and Tc-99m HMDP scintigraphic findings in extraskeletal osteosarcoma.
Kajihara M; Sugawara Y; Miki H; Mochizuki T; Kidani T; Sakayama K
Clin Nucl Med; 2005 May; 30(5):356-8. PubMed ID: 15827415
[TBL] [Abstract][Full Text] [Related]
5. Characterization of different osteosarcoma phenotypes by PET imaging in preclinical animal models.
Campanile C; Arlt MJ; Krämer SD; Honer M; Gvozdenovic A; Brennecke P; Fischer CR; Sabile AA; Müller A; Ametamey SM; Born W; Schibli R; Fuchs B
J Nucl Med; 2013 Aug; 54(8):1362-8. PubMed ID: 23801674
[TBL] [Abstract][Full Text] [Related]
6. (99m)Tc-MDP uptake in soft-tissue osteosarcoma in a dog.
Lass P; Krzemiński M; Teodorczyk J
Nucl Med Rev Cent East Eur; 2004; 7(2):189. PubMed ID: 15968610
[No Abstract] [Full Text] [Related]
7. Non-invasive imaging correlates with histological and molecular characteristics of an osteosarcoma model: application for early detection and follow-up of MDR phenotype.
Dutour A; Leclers D; Monteil J; Paraf F; Charissoux JL; Rousseau R; Rigaud M
Anticancer Res; 2007; 27(6B):4171-8. PubMed ID: 18225588
[TBL] [Abstract][Full Text] [Related]
8. [Visualization of pulmonary metastasis of osteosarcoma with 99mTc-HMDP].
Hervás Benito I; González Cabezas P; Saura Quiles A; Pérez Velasco R; Bello Arques P; Mateo Navarro A
Rev Esp Med Nucl; 2001 Dec; 20(7):558-9. PubMed ID: 11709142
[No Abstract] [Full Text] [Related]
9. In-vivo near-infrared optical imaging of growing osteosarcoma cell lesions xenografted in mice: dual-channel quantitative evaluation of volume and mineralization.
Nakayama H; Kawase T; Okuda K; Wolff LF; Yoshie H
Acta Radiol; 2011 Nov; 52(9):978-88. PubMed ID: 21969703
[TBL] [Abstract][Full Text] [Related]
10. First preclinical imaging of primary cartilage neoplasm and its local recurrence using 99mTc-NTP 15-5 radiotracer.
Miot-Noirault E; Gouin F; Vidal A; Rapp M; Maublant J; Askienazy S; Chezal JM; Heymann D; Redini F; Moins N
J Nucl Med; 2009 Sep; 50(9):1541-7. PubMed ID: 19690026
[TBL] [Abstract][Full Text] [Related]
11. Conventional 99mTc-(hydroxy) methylene diphosphate remains useful to predict osteosarcoma response to neoadjuvant chemotherapy: Individual patient data and aggregate data meta-analyses.
Kubo T; Furuta T; Sakuda T; Ochi M; Adachi N
Medicine (Baltimore); 2018 Dec; 97(51):e13308. PubMed ID: 30572434
[TBL] [Abstract][Full Text] [Related]
12. Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibi.
Gomes CM; Welling M; Que I; Henriquez NV; van der Pluijm G; Romeo S; Abrunhosa AJ; Botelho MF; Hogendoorn PC; Pauwels EK; Cleton-Jansen AM
Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1793-803. PubMed ID: 17541583
[TBL] [Abstract][Full Text] [Related]
13. A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcoma.
Stokkel MP; Linthorst MF; Borm JJ; Taminiau AH; Pauwels EK
J Cancer Res Clin Oncol; 2002 Jul; 128(7):393-9. PubMed ID: 12136254
[TBL] [Abstract][Full Text] [Related]
14. Tl-201, Tc-99m sestamibi, and Tc-99m HMDP uptake in multiple brown tumors.
Ohnishi H; Abe M; Miyagawa M; Nishimura K
Clin Nucl Med; 2003 Jul; 28(7):601-3. PubMed ID: 12819422
[No Abstract] [Full Text] [Related]
15. An unusual case of juxtacortical osteosarcoma presenting on Tc-99m MDP bone scan with central photopenia.
Biega TL; Mallari PM; Kim SY
Clin Nucl Med; 2004 Feb; 29(2):112-4. PubMed ID: 14734911
[No Abstract] [Full Text] [Related]
16. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET SUVmax correlates with osteosarcoma histologic response to neoadjuvant chemotherapy: preclinical evaluation in an orthotopic rat model.
Dutour A; Decouvelaere AV; Monteil J; Duclos ME; Roualdes O; Rousseau R; Marec-Bérard P
J Nucl Med; 2009 Sep; 50(9):1533-40. PubMed ID: 19690032
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m MDP bone scintigraphy in a patient with multicentric osteosarcoma.
Cermik TF; Salan A; Firat MF; Berkarda S
Clin Nucl Med; 2003 Jul; 28(7):599-600. PubMed ID: 12819421
[No Abstract] [Full Text] [Related]
19. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
20. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]